CURRENT REPORT

Company

Actinium Pharmaceuticals, Inc.

Filed

December 19, 2019

Period of Report

December 18, 2019

Accession Number

0001213900-19-026593

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →